Standard Biotools (LAB) Operating Expenses (2010 - 2026)

Standard Biotools (LAB) has 17 years of Operating Expenses data on file, last reported at $23.8 million in Q1 2026.

• On a quarterly basis, Operating Expenses fell 37.39% year-over-year to $23.8 million in Q1 2026; TTM through Mar 2026 was $138.6 million, a 10.55% decrease from a year earlier, with the FY2025 full-year figure at $152.8 million, down 11.36% from the prior year.
• Operating Expenses for Q1 2026 stood at $23.8 million, down from $36.0 million in the prior quarter.
• Over the last five years, Operating Expenses for LAB reached as high as $84.4 million in Q1 2024 and fell as low as $23.8 million in Q1 2026.
• Historically, Operating Expenses has averaged $39.6 million across 5 years, with a median of $37.4 million in 2024.
• Across the five-year window, Operating Expenses plunged 74.25% in 2022 and surged 192.2% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $32.3 million in 2022, then rose by 7.63% to $34.7 million in 2023, then gained by 7.76% to $37.4 million in 2024, then declined by 3.77% to $36.0 million in 2025, then plunged by 33.93% to $23.8 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $23.8 million in Q1 2026, $36.0 million in Q4 2025, and $42.4 million in Q3 2025.